Predictive factors for toxicity and survival of second-line sunitinib in advanced gastrointestinal stromal tumours (GIST).

Den Hollander, D; Van der Graaf, W T A; Desar, I M E; Le Cesne, A

Den Hollander, D; Van der Graaf, W T A; Desar, I M E; Le Cesne, A.

Affiliation

Den Hollander D; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Van der Graaf WTA; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
Desar IME; Department of Medical Oncology, Netherlands Cancer Institute, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Le Cesne A; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Acta Oncol ; 58(11): 1648-1654, 2019 Nov.

Article in En | MEDLINE | ID: mdl-31345082

Subject(s)

Antineoplastic Agents/adverse effects; Gastrointestinal Neoplasms/drug therapy; Gastrointestinal Stromal Tumors/drug therapy; Sunitinib/adverse effects; Adult; Age Factors; Aged; Aged, 80 and over; Antineoplastic Agents/administration & dosage; Female; Gastrointestinal Neoplasms/mortality; Gastrointestinal Neoplasms/pathology; Gastrointestinal Stromal Tumors/mortality; Gastrointestinal Stromal Tumors/pathology; Humans; Imatinib Mesylate/therapeutic use; Male; Middle Aged; Progression-Free Survival; Retrospective Studies; Risk Factors; Sunitinib/administration & dosage; Survival Rate; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gastrointestinal Stromal Tumors / Sunitinib / Gastrointestinal Neoplasms / Antineoplastic Agents Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Acta Oncol Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Netherlands

Fulltext

XML

PubMed Links

Search on Google